CRIS Current Research Information System

MANES, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.733
AS - Asia 4.292
EU - Europa 3.339
AF - Africa 291
SA - Sud America 253
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.919
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.665
VN - Vietnam 1.244
SG - Singapore 1.088
CN - Cina 1.061
GB - Regno Unito 787
IT - Italia 735
DE - Germania 396
HK - Hong Kong 317
SE - Svezia 270
UA - Ucraina 253
FR - Francia 225
BR - Brasile 176
IN - India 171
RU - Federazione Russa 158
IE - Irlanda 156
NL - Olanda 107
CI - Costa d'Avorio 84
ZA - Sudafrica 78
JP - Giappone 68
TG - Togo 62
KR - Corea 59
EE - Estonia 52
JO - Giordania 46
BD - Bangladesh 45
CA - Canada 45
FI - Finlandia 45
PH - Filippine 34
AR - Argentina 33
CH - Svizzera 28
TH - Thailandia 27
BG - Bulgaria 24
SC - Seychelles 24
ID - Indonesia 21
BE - Belgio 18
PL - Polonia 16
IQ - Iraq 15
NG - Nigeria 15
TW - Taiwan 15
AT - Austria 14
CO - Colombia 14
IR - Iran 14
TR - Turchia 14
EC - Ecuador 11
PK - Pakistan 10
MX - Messico 9
SA - Arabia Saudita 9
GR - Grecia 8
ES - Italia 7
AU - Australia 6
JM - Giamaica 6
VE - Venezuela 6
EG - Egitto 5
MY - Malesia 5
PS - Palestinian Territory 5
UZ - Uzbekistan 5
AL - Albania 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
DZ - Algeria 4
HR - Croazia 4
KE - Kenya 4
LT - Lituania 4
OM - Oman 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
ET - Etiopia 3
HN - Honduras 3
MA - Marocco 3
MK - Macedonia 3
PE - Perù 3
RO - Romania 3
UY - Uruguay 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
EU - Europa 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
MT - Malta 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TN - Tunisia 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
HU - Ungheria 1
IS - Islanda 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
Totale 12.915
Salva come PNG Salva come JPEG
Città #
Singapore 733
Southend 676
Chandler 452
Ashburn 441
Fairfield 418
Hong Kong 302
Santa Clara 250
Ho Chi Minh City 242
Hanoi 237
San Jose 235
Woodbridge 203
Wilmington 195
Dong Ket 188
Houston 182
Beijing 174
Seattle 165
Princeton 162
Dublin 155
Cambridge 145
Ann Arbor 140
Jacksonville 139
Hefei 123
Boardman 99
Bologna 91
Abidjan 84
Lauterbourg 77
Padova 77
Nanjing 74
Milan 71
Westminster 68
Tokyo 63
Lomé 62
Los Angeles 57
Council Bluffs 55
Berlin 53
Turin 52
Buffalo 49
New York 47
Amman 46
Jinan 45
São Paulo 44
Seoul 42
Haiphong 35
Helsinki 35
Saint Petersburg 35
Shenyang 35
Medford 32
Da Nang 29
Hebei 28
Mülheim 28
Dallas 26
San Diego 23
Changsha 22
Guangzhou 22
Nanchang 21
Sofia 21
Hangzhou 20
Jiaxing 20
Bern 19
Des Moines 19
Bengaluru 18
Brussels 18
Redondo Beach 18
Rome 18
Mahé 17
Munich 17
Dearborn 16
Abeokuta 15
Frankfurt am Main 15
London 15
The Dalles 15
Tianjin 15
Florence 14
Toronto 14
Montreal 13
Amsterdam 12
Can Tho 12
Orem 12
Shanghai 12
Warsaw 12
Zhengzhou 12
Johannesburg 11
Monmouth Junction 11
Olalla 11
Paris 11
Biên Hòa 10
Bremen 10
Falkenstein 10
Ningbo 10
Ninh Bình 10
Phoenix 10
Redmond 10
Verona 10
Chengdu 9
Falls Church 9
Norwalk 9
Yubileyny 9
Ardabil 8
Bogotá 8
Haikou 8
Totale 8.177
Salva come PNG Salva come JPEG
Nome #
Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells 271
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 266
Complicanze del cateterismo cardiaco destro in pazienti con ipertensione polmonare precapillare di grado severo. 257
Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients 250
A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension 247
Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: Real-world insights 239
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 235
Il test acuto di vasoreattività nei pazienti con ipertensione arteriosa polmonare. 234
Pulmonary Arterial Hypertension associated to connective tissue diseases 226
Effetti emodinamici e funzionali dell'epoprostenolo in associazione agli antagonisti recettoriali dell'endotelina e agli inibitori delle fosfodiesterasi-5 225
Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes 214
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension 213
Regressione delle alterazioni elettrocardiografiche indicative di ipertrofia ventricolare destra nei pazienti con ipertensione arteriosa polmonare. 203
Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease 203
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 195
BMPR2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis 195
Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration 194
Andamento clinico, emodinamico e dei livelli plasmatici dell’NT-pro BNP in pazienti con ipertensione polmonare precapillare 191
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. 191
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 187
A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines 185
Effetti del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare idiopatica, associata e cuore polmonare cronico tromboembolico. 181
Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension. 177
Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida. 175
Current therapeutic approaches to pulmonary arterial hypertension. 174
New insights on pulmonary arterial hypertension. 173
The endothelin system in pulmonary arterial hypertension. 173
Effetti clinici ed emodinamici del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare. 173
Genere femminile e ipertensione arteriosa polmonare: una relazione complessa Female gender and pulmonary arterial hypertension: a complex relationship 173
Evaluation of pulmonary arterial hypertension. 170
BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. 170
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. 168
Sildenafil therapy in patients with porto-pulmonary hypertension 167
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 167
Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors 165
Confronto tra antagonista recettoriali selettivi e non selettivi dell'endotelina nel trattamento dell'ipertensione arteriosa polmonare. 162
Cardiologia pediatrica. Problematiche cliniche 160
Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature. 159
Pulmonary arterial hypertension. Part II: Medical and surgical treatment 158
Effetti del sildenafil in soggetti con cuore polmonare cronico tromboembolico 158
Pulmonary veno-occlusive disease: the role of CT 151
Reverse remodelling of ECG changes in idiopathic pulmonary arterial hypertension patients responders to chronic treatment with calcium channel blockers 151
Effetti a lungo termine del trattamento con bosentan sulla capacità funzionale e sui parametri emodinamici nei pazienti con ipertensione arteriosa polmonare. 149
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger's Syndrome. 147
Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation. 146
Effetti a lungo termine del trattamento con sildenafil nei pazienti affetti da ipertensione arteriosa polmonare associata a cardiopatie congenite con shunt 145
Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease 144
Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. 143
Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects 142
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 142
Exercise training in pulmonary hypertension: improving performance but waiting for outcome 139
The difficult diagnosis of pulmonary vascular disease in heart failure 136
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension 135
L. Negro, M. Zavatta, C. Bachetti, E. Beciani, M. Palazzini, S. Romanazzi, E. Leci, M. Grossi, A. Marinelli, S. Gambetti, A. Manes, N. Galiè, A. Branzi 135
L-arginine supplementation in pulmonary arterial hypertension 134
Comparative analysis of clinical trials and evidence-based treatment algorithm for pulmonary arterial hypertension 134
Epidemiology of patients referred to a specialised pulmonary hypertension center 134
Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools 134
Conventional Medical Therapies in the treatment of pulmonary hypertension 133
Long-term efficacy and safety of sildenafil in precapillary pulmonary hypertension 133
Current medical therapies in pulmonary arterial hypertension 128
Pulmonary arterial hypertension in the pediatric age. 128
Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research† 128
New Treatment Strategies for Pulmonary Arterial Hypertension 126
Thrombolysis in high-risk patients with acute pulmonary embolism: underuse of a life-saving treatment in the real-world setting 126
Experience with inheritable pulmonary arterial hypertension in a specialised center 125
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. 123
Progressi nel trattamento delle malattie della circolazione polmonare 122
Long-term outcomes after pulmonary endarterectomy 122
GPs meet rare lung disorders task force factsheet: Pulmonary arterial hypertension 119
Pulmonary hypertension 116
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed. 114
Ipertensione polmonare: Necessità di chiarezza tra definizione emodinamica-fisiopatologica, stima ecocardiografica e diagnosi clinica finale. Pulmonary hypertension and the relationships between hemodynamic-pathophysiologic definitions, echocardiographic estimate and final clinical diagnosis: clarification is needed. 103
Pulmonary Hypertension: Lessons from Adults 103
Pulmonary Hypertension 100
Predictive value of tricuspid regurgitation area in idiopathic pulmonary arterial hypertension patients treated according to current guidelines 97
Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease 94
Chronic Thromboembolic Pulmonary Hypertension and Chronic ThromboembolicPulmonary Disease (CTEPD): Clinical and Interventional Perspective 94
Malattie del circolo polmonare 89
Comparison of different treatment strategies in patients with chronic thromboembolic pulmonary hypertension: a single centre real-world experience 86
Metrics for Success of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension 84
Diagnosis of Chronic Thromboembolic Pulmonary Hypertension 73
Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds 68
Influence of age in the assessment of therapeutic response in patients with pulmonary arterial hypertension 62
Totale 13.161
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.802
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021389 0 0 0 0 0 0 0 0 0 0 0 389
2021/20221.412 104 79 90 132 110 77 30 70 52 113 282 273
2022/20231.820 185 251 80 249 87 145 50 90 346 86 143 108
2023/2024317 25 64 22 30 28 40 24 9 12 24 26 13
2024/20251.884 60 338 225 100 336 86 109 61 32 122 42 373
2025/20264.043 321 373 342 286 481 221 346 117 927 334 163 132
Totale 13.161